9514 Fair Value & Analysis
Basic Materials · Market cap 238M SAR
Fair value as of: Jul 31, 2026
From 26 valuation models · updated today
Share price −8.6% over the past month.
What matters now
- The price sits above even our optimistic bull case (27.60 SAR). The favourable scenario is already priced in.
- Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (10.99 SAR to 27.60 SAR) leaves room in how you read the outcome.
Price vs Fair Value (12 months)
12‑month range 17.69 SAR – 44.80 SAR · fair‑value band 10.99 SAR – 27.60 SAR · the 40.96 SAR price screens above the 21.42 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
9514 (9514) currently trades at 40.96 SAR, while our model-based Fair Value estimate is 21.42 SAR, implying the stock looks roughly 47.7% overvalued today. We read business quality at 65/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, 9514 generated revenue of 83.8M SAR at a net margin of 9.1%. Revenue grew 18.2% year over year. It earns a return on equity of 13.4%. Net debt stands at 17.5M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 10.99 SAR (bear case) to 27.60 SAR (bull case); at 40.96 SAR, the current price sits above that range. The share trades about 10% below its 52-week high and 139% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -55% fair-value upside, at -48%, 9514 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
9514 reported revenue of 80.9M SAR in FY2025 versus 53.3M SAR in FY2021, a compound +11.0%/yr. Reported net income was 7.5M SAR in FY2025, compounding −4.9%/yr from FY2021.
Is 9514 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CRH plc CRH | $111.25 | $70.25 | -37% |
| Holcim AG HCMLY | $19.20 | $8.68 | -55% |
| UltraTech Cement Limited ULTRACEMCO | ₹10,912 | ₹4,589 | -58% |
| China Jushi Co 600176 | ¥58.38 | ¥15.13 | -74% |
| Grasim Industries Limited GRASIM | ₹3,175 | ₹1,257 | -60% |
| CEMEX, S.A. CEMEXCPO | 21.03 MXN | 17.45 MXN | -17% |
| Anhui Conch Cement Company 600585 | ¥17.86 | ¥38.10 | +113% |
| Ambuja Cements Limited AMBUJACEM | ₹428.00 | ₹227.96 | -47% |
| Shree Cement Limited SHREECEM | ₹25,035 | ₹8,215 | -67% |
| TCC Group 1101B | 45.30 TWD | 2.54 TWD | -94% |
Compare 9514 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is 9514 overvalued or undervalued?
What is the fair value of 9514?
What is the quality score of 9514?
What is the revenue of 9514?
What is the net profit margin of 9514?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 9514 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.